Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(9):718-719; doi:10.1093/jnci/djh139
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Lee, C. T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lee, C. T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

CORRESPONDENCE

RE: Racial Differences in Mortality Among Medicare Recipients After Treatment for Localized Prostate Cancer

Cheryl T. Lee

Affiliation of author: Michigan Urology Center, University of Michigan, Ann Arbor, MI.

Correspondence to: Cheryl T. Lee, MD, Comprehensive Cancer Center, University of Michigan, 7303 CCGC, 1500 E. Medical Center Dr., Ann Arbor, MI 48109-0946 (e-mail: ctlee@umich.edu)

The first 10% of the full text of this article appears below.

The recent article by Godley et al. (1) raises important concerns for those who manage localized prostate cancer. The authors found that African Americans who underwent surgery, radiation, or non-aggressive therapy for localized prostate cancer had a median overall survival that was 1.8, 0.7, and 1.0 years less than that of Caucasians treated with the same respective modality. Moreover, a significant disadvantage in overall survival was seen in African . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?